Simvastatin accelerates the healing process of burn wound in Wistar rats through Akt/mTOR signaling pathway
•Topical Smv administered as an Akt/mTOR signaling activator may improve the healing process of burn wounds.•The Smv accelerated wound closure and increased CD31, VEGF, and α-SMA protein levels.•The gene expression and protein level of Akt, mTOR, p-Akt, and p-mTOR were significantly increased in the...
Gespeichert in:
Veröffentlicht in: | Annals of anatomy 2021-07, Vol.236, p.151652-151652, Article 151652 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | •Topical Smv administered as an Akt/mTOR signaling activator may improve the healing process of burn wounds.•The Smv accelerated wound closure and increased CD31, VEGF, and α-SMA protein levels.•The gene expression and protein level of Akt, mTOR, p-Akt, and p-mTOR were significantly increased in the treatment group with Smv.
Statins, apart from cholesterol-lowering properties, have wound healing effects. Hereby, we aimed to assess the impact of Simvastatin (SMV), one of the most commonly used statins, on Akt/mTOR signaling pathway during burn wound healing process. After creating a second-degree burn on the dorsal area of adult male Wistar rats (n = 60), they were randomly divided into the control, SMV, vehicle of Simvastatin (SMV-Veh), Rapamycin (RM), vehicle of Rapamycin (RM-Veh), and combined SMV and RM (SMV + RM) groups. The animals were sacrificed on the 7th and 14th post-burn days and wound tissue samples were collected for histologic, immunohistochemical, quantitative real-time polymerase chain reaction (qRT-PCR), and western blot investigations. Rapamycin (RM) was also used to treat animals as an mTOR inhibitor. Topical administration of SMV resulted in a faster healing rate, elevated collagen deposition, and increased myofibroblast population compared to other experimental groups. Moreover, qRT-PCR findings showed that the wounds treated with SMV alone had the highest expression levels of CD31, VEGF, Akt, mTOR, and p70S6K after 7 and 14 days of burn model (p < 0.001). According to western blot findings, daily topical treatment with SMV further increased protein levels of P-AktThr308, P-mTORSer2448, and P-p70S6 KThr389 compared with other treatments, at both follow-up time points (p < 0.001). In contrast, inhibition of Akt/mTOR signaling pathway by RM reduced SMV-induced wound healing process. Seemingly, SMV promotes burn wound healing, at least in part, through activating Akt/mTOR signaling pathway, suggesting topically applied SMV as an alternative therapeutic approach for managing burn wound healing. |
---|---|
ISSN: | 0940-9602 1618-0402 |
DOI: | 10.1016/j.aanat.2020.151652 |